Health Canada has approved the use of the Pfizer/BioNTech Comirnaty vaccine against COVID-19 in children aged five to 11 years. The agency’s press office announced this on Friday, November 19.
It is noted that the vaccine was initially approved for use in citizens aged 16 years and older in December 2020, and then it was approved for children aged 12 to 15 years in May 2021.
“After a thorough and independent scientific review, the department determined that the benefits of this vaccine for children aged five to 11 years outweigh the risks. Health Canada has authorized two doses of 10 micrograms administered with a three-week regimen, a lower dose than the two-dose, 30-microgram regimen authorized for people ages 12 and older,” the statement said.
Earlier, on November 14, the press service of the Israeli Ministry of Health reported that Israeli Health Ministry Director General Nachman Ash approved the recommendation of the federal agency’s expert council to vaccinate children between the ages of five and 11 against COVID-19. The plan is to vaccinate children in this age group against the coronavirus with a Pfizer product.
On November 6, Costa Rica became the first country in the world to implement compulsory vaccination against coronavirus for children from five to 11 years old. In October, Costa Rica announced the purchase of 3.5 million doses of the vaccine from Pfizer. About 1.5 million of these will be used to vaccinate children.
At the same time in March it was reported that in Switzerland, since the beginning of vaccination against coronavirus almost 600 cases of side effects after vaccination were revealed. 343 cases of side effects were recorded when using the Comirnaty vaccine from Pfizer/BioNTech, and another 251 cases after vaccination with Moderna.